Endothelial Progenitor Cell-Derived Extracellular Vesicles: Potential Therapeutic Application in Tissue Repair and Regeneration
Open Access
- 15 June 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (12) , 6375
Abstract
Recently, many studies investigated the role of a specific type of stem cell named the endothelial progenitor cell (EPC) in tissue regeneration and repair. EPCs represent a heterogeneous population of mononuclear cells resident in the adult bone marrow. EPCs can migrate and differentiate in injured sites or act in a paracrine way. Among the EPCs’ secretome, extracellular vesicles (EVs) gained relevance due to their possible use for cell-free biological therapy. They are more biocompatible, less immunogenic, and present a lower oncological risk compared to cell-based options. EVs can efficiently pass the pulmonary filter and deliver to target tissues different molecules, such as micro-RNA, growth factors, cytokines, chemokines, and non-coding RNAs. Their effects are often analogous to their cellular counterparts, and EPC-derived EVs have been tested in vitro and on animal models to treat several medical conditions, including ischemic stroke, myocardial infarction, diabetes, and acute kidney injury. EPC-derived EVs have also been studied for bone, brain, and lung regeneration and as carriers for drug delivery. This review will discuss the pre-clinical evidence regarding EPC-derived EVs in the different disease models and regenerative settings. Moreover, we will discuss the translation of their use into clinical practice and the possible limitations of this process.Keywords
This publication has 133 references indexed in Scilit:
- The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluidsFrontiers in Genetics, 2013
- Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart functionProceedings of the National Academy of Sciences, 2012
- Exosome mimetics: a novel class of drug delivery systemsInternational Journal of Nanomedicine, 2012
- Calcimimetic R-568 and Its Enantiomer S-568 Increase Nitric Oxide Release in Human Endothelial CellsPLOS ONE, 2012
- Cell‐derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?Journal of Cellular and Molecular Medicine, 2011
- The biology of fracture healingInjury, 2011
- MicroRNA miR-137 Regulates Neuronal Maturation by Targeting Ubiquitin Ligase Mind Bomb-1Stem Cells, 2010
- Biomaterial technology for tissue engineering applicationsJournal of The Royal Society Interface, 2009
- Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentratorAmerican Journal of Physiology-Renal Physiology, 2007
- Osteoclasts: What Do They Do and How Do They Do It?The American Journal of Pathology, 2007